Home › European Commission Approves RELVAR ELLIPTA To Treat Asthma And COPD
 

Keywords :   


European Commission Approves RELVAR ELLIPTA To Treat Asthma And COPD

2013-11-21 09:36:25| drugdiscoveryonline News Articles

RELVAR® ELLIPTA® has been given marketing authorization by the European Commission for the treatment of asthma and COPD.

Tags: european commission treat european commission

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Tropical Storm Lane Graphics
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Forecast Discussion Number 4
02.11Subtropical Storm Patty Wind Speed Probabilities Number 2
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Public Advisory Number 2
02.11Subtropical Storm Patty Forecast Advisory Number 2
02.11Subtropical Storm Patty Update Statement
More »